[AQUATIC trial: ending the aspirin era in anticoagulated patients after percutaneous coronary intervention]
Related Experiment Video
Updated: Jan 7, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Felice Gragnano1, Paolo Calabrò1
1Dipartimento di Scienze Mediche Traslazionali, Università degli Studi della Campania "Luigi Vanvitelli", Caserta - U.O.C. Cardiologia a Direzione Universitaria, Dipartimento Cardio-Vascolare, AORN "Sant'Anna e San Sebastiano", Caserta.
No abstract available in PubMed .
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins

